Carisoprodol Tablet
Product Images NDC 45865-233

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 45865-233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

233 (45865 233)

Carisoprodol Tablets 350 mg oral tablet label, generic for Soma, Schedule CIV controlled substance. Label indicates 60 tablets per bottle, manufactured by Oxford Pharm in Birmingham, AL. Includes cautionary notes about habit formation, dizziness, drowsiness, and alcohol avoidance. Distributed by Medsource Pharmaceuticals.*

FDA Label Image

Structural Formula (Structure)

Chemical structure of carisoprodol, showing the molecular arrangement of atoms and bonds in the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.